180 related articles for article (PubMed ID: 20374708)
1. Protein arginine methyltransferases: nuclear receptor coregulators and beyond.
Kuhn P; Xu W
Prog Mol Biol Transl Sci; 2009; 87():299-342. PubMed ID: 20374708
[TBL] [Abstract][Full Text] [Related]
2. Assaying epigenome functions of PRMTs and their substrates.
Rakow S; Pullamsetti SS; Bauer UM; Bouchard C
Methods; 2020 Mar; 175():53-65. PubMed ID: 31542509
[TBL] [Abstract][Full Text] [Related]
3. A patent review of arginine methyltransferase inhibitors (2010-2018).
Li X; Wang C; Jiang H; Luo C
Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
[TBL] [Abstract][Full Text] [Related]
4. A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes.
Iyamu ID; Al-Hamashi AA; Huang R
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34201091
[TBL] [Abstract][Full Text] [Related]
5. Chemical probes for protein arginine methyltransferases.
Li ASM; Li F; Eram MS; Bolotokova A; Dela Seña CC; Vedadi M
Methods; 2020 Mar; 175():30-43. PubMed ID: 31809836
[TBL] [Abstract][Full Text] [Related]
6. Non-Histone Arginine Methylation by Protein Arginine Methyltransferases.
Al-Hamashi AA; Diaz K; Huang R
Curr Protein Pept Sci; 2020; 21(7):699-712. PubMed ID: 32379587
[TBL] [Abstract][Full Text] [Related]
7. Using affinity purification coupled with stable isotope labeling by amino acids in cell culture quantitative mass spectrometry to identify novel interactors/substrates of protein arginine methyltransferases.
Morettin A; Bourassa J; Mahadevan K; Trinkle-Mulcahy L; Cote J
Methods; 2020 Mar; 175():44-52. PubMed ID: 31794835
[TBL] [Abstract][Full Text] [Related]
8. Peptidic transition state analogues as PRMT inhibitors.
Zhang Y; van Haren MJ; Martin NI
Methods; 2020 Mar; 175():24-29. PubMed ID: 31421210
[TBL] [Abstract][Full Text] [Related]
9. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs).
Morales Y; Cáceres T; May K; Hevel JM
Arch Biochem Biophys; 2016 Jan; 590():138-152. PubMed ID: 26612103
[TBL] [Abstract][Full Text] [Related]
10. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
Obianyo O; Thompson PR
J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based virtual screening and biological evaluation of small molecule inhibitors for protein arginine methylation.
Wang J; Chen L; Sinha SH; Liang Z; Chai H; Muniyan S; Chou YW; Yang C; Yan L; Feng Y; Li KK; Lin MF; Jiang H; Zheng YG; Luo C
J Med Chem; 2012 Sep; 55(18):7978-87. PubMed ID: 22928876
[TBL] [Abstract][Full Text] [Related]
12. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
[TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level.
Tewary SK; Zheng YG; Ho MC
Cell Mol Life Sci; 2019 Aug; 76(15):2917-2932. PubMed ID: 31123777
[TBL] [Abstract][Full Text] [Related]
14. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
[TBL] [Abstract][Full Text] [Related]
15. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
Gao Y; Feng C; Ma J; Yan Q
Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
[TBL] [Abstract][Full Text] [Related]
16. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
Elife; 2022 Jan; 11():. PubMed ID: 34984976
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferases: promising targets for cancer therapy.
Hwang JW; Cho Y; Bae GU; Kim SN; Kim YK
Exp Mol Med; 2021 May; 53(5):788-808. PubMed ID: 34006904
[TBL] [Abstract][Full Text] [Related]
18. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
[TBL] [Abstract][Full Text] [Related]
19. Protein arginine methyltransferases (PRMTs) as therapeutic targets.
Cha B; Jho EH
Expert Opin Ther Targets; 2012 Jul; 16(7):651-64. PubMed ID: 22621686
[TBL] [Abstract][Full Text] [Related]
20. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]